BERKLEY W R CORP - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 11 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BERKLEY W R CORP ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$512,581
-51.4%
47,199
-51.2%
0.03%
-47.6%
Q2 2023$1,054,869
-0.4%
96,777
-2.4%
0.06%
-6.0%
Q1 2023$1,058,997
-73.0%
99,157
-74.2%
0.07%
-68.4%
Q4 2022$3,915,918
+0.9%
384,6300.0%0.21%
+12.8%
Q3 2022$3,881,000
+30.5%
384,630
+29.6%
0.19%
+27.9%
Q2 2022$2,973,000
+0.1%
296,7300.0%0.15%
-3.3%
Q1 2022$2,969,000
+1.0%
296,7300.0%0.15%
-6.2%
Q4 2021$2,941,000296,7300.16%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2023
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders